Exenatide treatment causes suppression of serum fasting ghrelin levels in patients with type 2 diabetes Mellitus

---

KÜÇÜKSARAÇ KIYICI D. S., Güçlü M., GÜL Z., ÇAVUN S.

19th European Congress of Endocrinology 2017, Lisbon, Portugal, 20 - 23 May 2017, vol.49, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Volume: 49
• Doi Number: 10.1530/endoabs.49.gp112
• City: Lisbon
• Country: Portugal
• Bursa Uludag University Affiliated: Yes